Flash Finance

Soni Medicare Ltd539378Corporate

Hospital Latest results: Jun 2026 14 quarters of data
₹69.35
MCap ₹30 Cr
Soni Medicare Ltd — Stock analysis & AI research Soni Medicare Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹5 Cr
Sales · Jun 2026
-39.2% YoY
₹-1 Cr
Operating Profit · Jun 2026
-1084.3% YoY
-19.5%
OPM % · Jun 2026
-1725.0% YoY
₹-1 Cr
Net Profit · Jun 2026
-313.3% YoY
₹-2.81
EPS · Jun 2026
-313.2% YoY

📝 Soni Medicare Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Soni Medicare Ltd reported revenue of ₹5 crore for the quarter ended June 2026 (Q1 FY27), down 39.2% from ₹7 crore in the same quarter last year, and down 30.8% sequentially over the March 2026 quarter.

The company reported a net loss of ₹1 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-2.81.

Operating profit stood at ₹-1 crore — an operating margin (OPM) of -19.5%, compared with 1.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Soni Medicare Ltd posted revenue of ₹26 crore, a decline of 15.9% over FY25, with a net loss of ₹3 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹23 crore with a net loss of ₹4 crore.

Valuation snapshot

At the current price of ₹69.35, 539378 has a market capitalisation of ₹30 crore.

Within the Hospital industry, it is the 9th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 69.79%, public shareholders 30.22% of Soni Medicare Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹30 Cr
Current Price ?
₹69.3
P/E ?
N/A
Industry P/E ?
39.60
P/B ?
-23.85
P/S ?
1.27
P/FCF ?
-53.78
Enterprise Value ?
₹43 Cr
EV/EBITDA ?
-22.67
PEG ?
N/A
Earnings Yield ?
-5.6%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹23 Cr
OPM ?
-8.1%
Profit after tax (TTM) ?
₹-4 Cr
EPS (TTM) ?
₹-8.48
ROCE ?
-12.1%
ROE ?
291.8%
ROA ?
-13.6%
Growth
Sales — latest qtr ?
₹5 Cr
PAT — latest qtr ?
₹-1 Cr
YoY qtr sales growth ?
-39.2%
YoY qtr profit growth ?
-313.3%
Sales growth (3y) ?
-2%
Sales growth (5y) ?
12%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹13 Cr
Debt to Equity ?
-10.44
Interest Coverage ?
-1.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
69.79%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-3.5%
Return 6 months ?
-1.2%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 68867798877675 -39.2% -30.8%
Operating Profit -000-1-0-11010-1-10-1 -1084.3% -592.2%
Other Income 00000000000000 — —
Interest 00000000000000 +57.8% +9.6%
Depreciation 00000000000000 +1.8% +1.8%
Profit Before Tax -100-1-1-10-00-0-1-1-0-1 -309.3% -282.9%
Net Profit -100-1-1-10-00-0-1-1-0-1 -313.3% -223.9%
EPS -2.130.210.07-2.13-2.09-2.041.10-0.300.82-0.68-2.16-2.65-0.87-2.81 -313.2% -223.0%
OPM % -8.1% 5.7% 4.6% -10.8% -6.6% -7.7% 10.1% 3.3% 9.3% 1.2% -7.8% -11.7% 2.7% -19.5% -1725.0% -822.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹31 Cr ₹26 Cr ₹23 Cr -15.9%
Operating Profit ₹1 Cr ₹-1 Cr ₹-2 Cr -170.9%
OPM % 4.07% -3.43% -8.05% -184.3%
NPM % -0.58% -10.33% -15.53% -1681.0%
Other Income ₹0 Cr ₹0 Cr ₹0 Cr —
Depreciation ₹0 Cr ₹1 Cr ₹1 Cr +4.0%
Interest ₹1 Cr ₹1 Cr ₹1 Cr +23.2%
EBIT ₹1 Cr ₹-1 Cr ₹-2 Cr -284.4%
PBT ₹-0 Cr ₹-3 Cr ₹-4 Cr -1100.0%
Tax — — ₹0 Cr —
Net Profit ₹-0 Cr ₹-3 Cr ₹-4 Cr -1405.6%
EPS ₹-0.42 ₹-6.36 ₹-8.49 -1414.3%
Material Cost — — ₹1 Cr —
Employee Cost — — ₹2 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 4.264.264.264.26 +0.0%
Reserves -0.97-2.65-2.97-5.50 -85.2%
Borrowings 8.729.7710.5212.95 +23.1%
Other Liabilities 8.088.2910.3514.97 +44.6%
Total Liabilities 20.0919.6722.1626.68 +20.4%
Fixed Assets 6.426.176.336.12 -3.3%
CWIP 0.000.000.000.00 —
Investments 0.040.040.040.59 +1375.0%
Other Assets 13.6313.4615.7919.97 +26.5%
Total Assets 20.0919.6722.1626.68 +20.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 0.210.391.47-0.26 -117.7%
Cash from Investing Activity -0.25-0.17-0.52-1.07 -105.8%
Cash from Financing Activity 0.310.21-0.241.21 +604.2%
Net Cash Flow 0.270.430.71-0.12 -116.9%
Free Cash Flow -0.180.120.81-0.55 -167.9%
CFO/OP -100%-26%-1,838%29% +101.6%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 103.6894.97107.15177.29 +65.5%
Inventory Days 20.7623.7738.2645.56 +19.1%
Days Payable 225.75223.30288.90545.62 +88.9%
Cash Conversion Cycle -101.31-104.57-143.49-322.78 -124.9%
Working Capital Days 0.2728.4017.001.11 -93.5%
ROCE % 0.77%-6.58%6.64%-12.07% -281.8%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 69.79%69.79%69.79%69.79% +0.0%
Public 30.21%30.22%30.22%30.22% +0.0%
No. of Shareholders 1,2431,2401,2451,237 -0.6%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 PARKHOSPS Park Medi ₹280.90 12,133 42.4 1,756 298 26.5% 16.9% — — 19.3% 34.8%
2 526783 Dr Agarwals ₹5,253.00 2,465 33.3 497 75 30.4% 15.2% 18.6% 27.8% 22.2% 37.5%
3 524520 KMC Speciality ₹81.32 2,373 23.8 331 57 30.4% 17.1% 32.5% 108.7% 37.0% 107.2%
4 GKSL Gujarat Kidney ₹172.33 1,359 — — — — — — — — —
5 543346 Aashka Hospitals ₹117.80 195 83.0 23 3 22.8% 14.5% — — 22.3% 55.2%
6 531658 Abate As ₹28.64 120 266.9 — 2 — — — 158.6% — 10.1%
7 523696 Fortis Malar ₹65.66 79 n/m 0 0 -5165.0% 427.8% — 932.5% -95.5% -96.3%
8 544013 KK Shah ₹49.79 30 — 9 -1 8.2% -6.6% — — -7.2% 57.1%
9 539378 Soni Medicare ₹26.49 30 — 23 -4 -8.1% -15.5% -15.9% -1405.6% -39.2% -313.3%
10 543520 Global Longlife ₹30.99 16 — — -2 — — — — — 61.5%
❓ Frequently asked questions
What was Soni Medicare Ltd's revenue in Q1 FY27?
Soni Medicare Ltd reported revenue of ₹5 crore for the quarter ended June 2026 (Q1 FY27), down 39.2% from ₹7 crore in the same quarter last year, and down 30.8% sequentially over the March 2026 quarter.
What was Soni Medicare Ltd's net profit in Q1 FY27?
The company reported a net loss of ₹1 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-2.81.
What is 539378's market capitalisation and P/E ratio?
At the current price of ₹69.35, 539378 has a market capitalisation of ₹30 crore.
Who owns Soni Medicare Ltd? (shareholding pattern)
As of Jun 2026, promoters held 69.79%, public shareholders 30.22% of Soni Medicare Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI